Boyer David W. — SEC insider filings
SEC reporting owner CIK 1909817. 21 insider filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2022-02-09 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 29 legs across 18 filings — 54,534 shares, $6,260,903 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 12,801 shares @ $102.41 ($1,310,985) in NEUROCRINE BIOSCIENCES INC, filed 2023-02-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Corp. Affairs Officer | 21 | — | 29 legs · 54,534 sh · $6,260,903 | 32 |
Insider filings — Boyer David W.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 3,587 @ $0 · Tax withholding (F): 1,936 @ $156.22 · Sale (S): 826 @ $157.45 | EDGAR |
| 2026-05-28 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 3,888 @ $156.64 | EDGAR |
| 2026-02-17 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,600 @ $0 · Tax withholding (F): 864 @ $123.10 · Option exercise (M): 1,541 @ $0 · Tax withholding (F): 832 @ $124.12 · Option exercise (M): 1,811 @ $0 · Tax withholding (F): 978 @ $124.12 · +7 more | EDGAR |
| 2026-02-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,096 @ $0 · Tax withholding (F): 1,189 @ $136.06 · Option exercise (M): 2,096 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,811 @ $0 · Sale (S): 955 @ $116.79 · Option exercise (M): 1,541 @ $0 · Sale (S): 830 @ $116.69 · Grant/award (A): 34,153 (derivative) @ $0 · Grant/award (A): 6,401 (derivative) @ $0 · +2 more | EDGAR |
| 2025-02-12 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,329 @ $0 · Sale (S): 700 @ $118.31 · Option exercise (M): 1,329 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,096 @ $0 · Sale (S): 1,104 @ $152.94 · Option exercise (M): 2,096 (derivative) @ $0 | EDGAR |
| 2024-10-07 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,295 @ $113.66 | EDGAR |
| 2024-09-17 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 3,461 @ $121.88 | EDGAR |
| 2024-02-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 955 @ $133.10 · Sale (S): 856 @ $133.05 · Grant/award (A): 30,977 (derivative) @ $0 · Grant/award (A): 6,165 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 240 @ $141.96 · Sale (S): 216 @ $141.96 · Sale (S): 700 @ $134.19 · Sale (S): 628 @ $136.78 | EDGAR |
| 2024-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,104 @ $140.87 · Sale (S): 992 @ $140.72 | EDGAR |
| 2023-10-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,437 @ $112.68 | EDGAR |
| 2023-09-01 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,295 @ $106.90 · Sale (S): 1,438 @ $108.22 | EDGAR |
| 2023-08-23 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,600 @ $107.41 | EDGAR |
| 2023-02-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 45,027 (derivative) @ $0 · Grant/award (A): 7,245 (derivative) @ $0 | EDGAR |
| 2023-02-08 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 240 @ $105.61 · Sale (S): 12,801 @ $102.41 · Sale (S): 11,497 @ $102.42 · Sale (S): 700 @ $104.11 | EDGAR |
| 2023-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,104 @ $109.92 | EDGAR |
| 2022-11-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,295 @ $114.12 | EDGAR |
| 2022-10-05 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,437 @ $106.59 | EDGAR |
| 2022-02-09 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 240 @ $81.07 · Sale (S): 700 @ $79.62 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-02-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1909817 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs